Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.

Infectious disorders drug targets - 1 Jan 2018

Sadeghi Leila, Lolaie Masoomeh, Tabatabai Reza Adl, Bayanolhagh Saeed, Taj Leila, Ahmadi Niloofar Eghbal, Abedinzadeh Negin, Vakili Farzaneh, Ahmadi Ghazaleh, Mohraz Minoo

Abstract excerpt

BACKGROUND: Determination of the drug-resistant mutations has a crucial role in the management of HIV-1 infected patients. OBJECTIVE: The aim of the current study was to evaluate drug resistance profile of Reverse transcriptase and Proteasegenes, and to find the correlation between drug resistance mutations and ART regimen to intensifyphysicians'options for the most effective therapy which could also influence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Protease Inhibitors

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 29663899
DOI: 10.2174/1871526518666180416110259

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.PMID 29663899Read ↗

A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 PatientsSemantic proximity Read ↗

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranSemantic proximity Read ↗

Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients.Semantic proximity Read ↗

Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014.Semantic proximity Read ↗

Phylogeny and drug resistance of HIV PR gene among HIV patients receiving RT inhibitors in IranSemantic proximity Read ↗

HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.Semantic proximity Read ↗

Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapySemantic proximity Read ↗

The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran.Semantic proximity Read ↗

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.Semantic proximity Read ↗

PREVALENCE AND STRUCTURE OF HIV-1 DRUG RESISTANCE AMONG TREATMENT NAÏVE PATIENTS SINCE THE INTRODUCTION OF ANTIRETROVIRAL THERAPY IN THE RUSSIAN FEDERATIONSemantic proximity Read ↗

Human Immunodeficiency Virus-1 Drug Resistance Mutations in Iranian Treatment-experienced Individuals.Semantic proximity Read ↗

Antiretroviral drug resistance among antiretroviral‐naïve and treatment experienced patients infected with HIV in IranSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.